Preferred Label : Myotonic dystrophy 2;
Symbol : DM2;
CISMeF acronym : DM2; PROMM;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Proximal myotonic myopathy; Ricker syndrome; Dystrophia myotonica 2; Myotonic myopathy, proximal; PROMM;
Description : Myotonic dystrophy (DM) is a multisystem disorder and the most common form of muscular
dystrophy in adults. Individuals with DM2 have muscle pain and stiffness, progressive
muscle weakness, myotonia, male hypogonadism, cardiac arrhythmias, diabetes, and early
cataracts. Other features may include cognitive dysfunction, hypersomnia, tremor,
and hearing loss (summary by Heatwole et al., 2011). See also myotonic dystrophy-1
(DM1; 160900), caused by an expanded CTG repeat in the dystrophia myotonica protein
kinase gene (DMPK; 605377) on 19q13. Although originally reported as 2 disorders,
myotonic dystrophy-2 and proximal myotonic myopathy are now referred to collectively
as DM2 (Udd et al., 2003).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by a (CCTG)n repeat expansion in the zinc finger protein 9 gene (ZNF9, 116955.0001);
Laboratory abnormalities : Elevated serum creatine kinase; Increased ALT; Increased cholesterol; Increased lactate dehydrogenase; Elevated gamma-glutamyltransferase (GGT); Decreased creatine; Decreased total protein;
Prefixed ID : #602668;
Origin ID : 602668;
UMLS CUI : C2931689;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)